Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, et al. PLoS One. 2016; 11(2):e0147567. Epub 2016 Feb 05. PMID: 26849221. Abstract CommentRecommendBookmarkWatch